TRENTON, N.J._Drugmaker Pfizer Inc. has sold $13.5 billion worth of bonds to replace short-term loans covering about one-third of the cost of its planned acquisition of rival Wyeth.  The senior, unsecured bonds were sold in groups with maturities of three, six, 10 and 20 years. IFR, a service of Thomson Reuters, said Bank of America, Barclays, Citigroup, Goldman Sachs and J.P. Morgan were among the bookrunners for the sale.  Pfizer's $68 billion cash, stock and debt deal to buy Wyeth includes borrowing $22.5 billion in a bridge loan arranged with five major investment banks. Last Thursday, Pfizer said in ... 
